Pfizer
Last updated: . For recent data, use our API.
Overview
We’re celebrating over 175 years of daring scientific innovation—and we’re not done yet. Let’s outdo yesterday. Protect your health at PfizerForAll.com
For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines
Private funding before listing
Disclosed funding: $5M across 1 round. Latest: POST IPO DEBT, 1 May 2025.
| Date | Type | Amount |
|---|---|---|
| 1 May 2025 | POST IPO DEBT | Not disclosed |
Office locations
- New York, US
- Mumbai, Maharashtra, IN
- Madison, New Jersey, US
- Newbridge, IE
- Groton, Connecticut, US
- New Taipei City, TW
- Sydney, New South Wales, AU
- Andover, Massachusetts, US
- Puurs, BE
- Sandton, Gauteng, ZA
- Collegeville, Pennsylvania, US
- Rochester, Michigan, US
- St-Laurent, Quebec, CA
- Almaty, KZ
- Singapore, SG
- Durham, North Carolina, US
- Herzliya, Tel-Aviv District, IL
- Seoul, KR
- Latina, Lazio, IT
Similar companies
- NovartisPharmaceutical Manufacturing · Basel, Baselstadt
- SanofiPharmaceutical Manufacturing · Paris, France
- Johnson & JohnsonHospitals and Health Care · New Brunswick, NJ
- AstraZenecaPharmaceutical Manufacturing · Cambridge, Cambridgeshire
- RocheBiotechnology Research
- GSKPharmaceutical Manufacturing · London, England
- Eli Lilly and CompanyPharmaceutical Manufacturing · Indianapolis, Indiana
- BayerChemical Manufacturing · Leverkusen, North Rhine-Westphalia
- AbbViePharmaceutical Manufacturing · North Chicago, Illinois
- Novo NordiskPharmaceutical Manufacturing
Recent posts from the Pfizer blog
- We’re proud to welcome the second class of Empowering Women in IBD Leadership Program!
Launched in 2025 by IOIBD - International Organization For the Study of Inflammatory Bowel Disease in collaboration with Pfizer, the program aims to help advance female leadership and representation in #gastroenterology.
- Pfizer will present more than 50 abstracts across our infectious disease pipeline and portfolio at #IDWeek2026.
These presentations showcase Pfizer’s significant advancements in the prevention and treatment of infectious diseases, including #pneumococcaldisease, #RSV, and #COVID19.